Cross-sectional Survey of Zhejiang ECMO Application

NCT04979325 | Unknown

• 1 other identifier: I2021001538
• Study Type: observational
• Target: 1
• Locations: 1 country
• Sites: 1

Brief Summary

Extracorporeal lung oxygenation (ECMO) was first used in neonates in the 1970s and is now widely used to treat adult patients with intractable shock and respiratory failure who have failed various types of conventional life support. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients worldwide received ECMO in 2019. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients were treated with ECMO worldwide in 2019, including 25,631 VV-ECOM, 12,836 VA, and 5086 ECPR. The number of ECMO cases and hospitals in Zhejiang province are increasing year by year, and they play an irreplaceable role in various critical care resuscitation, especially in response to public emergencies, but there is a lack of precise data on the current status of ECMO implementation. This study aims to investigate the implementation of ECMO, problems and needs of hospitals at all levels in Zhejiang Province, and provide reference for further improving the capacity and quality of ECMO application in the province.

Conditions

Extracorporeal Membrane Oxygenation; Cardiopulmonary Resuscitation; Epidemiology

Keywords

Extracorporeal membrane oxygenation; Epidemiology

Outcome Measures

Primary Outcomes (3)

• Contains the general description of the hospital

  including hospital level, nature, number of approved beds, total number of outpatient and emergency departments in 2019, number of discharges, and number of operations

  1 year

• ECMO configuration

  ECMO equipment manufacturers, models, number of ECMOs, belonging departments, and those who are proficient in ECMO Health care team

  1 year

• ECMO development status

  first case development time, independent hospital development time, number, type and number of weaning machines carried out in 2019, operating costs, etc

  1 year

Secondary Outcomes (1)

• Zhejiang Hospital's Cognitive Status of ECMO Development

  1 year

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

You may qualify if:

• All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

You may not qualify if:

• Hospitals that explicitly do not wish to participate

Sponsors & Collaborators

• Second Affiliated Hospital, School of Medicine, Zhejiang University: lead
• Sir Run Run Shaw Hospital: collaborator
• Zhejiang Provincial People's Hospital: collaborator
• Zhejiang Hospital: collaborator
• The First Affiliated Hospital of Zhejiang Chinese Medical University: collaborator
• First People's Hospital of Hangzhou: collaborator
• The Affiliated Hospital of Hangzhou Normal University: collaborator
• The Third People's Hospital of Hangzhou: collaborator
• Red Cross Hospital, Hangzhou, China: collaborator
• Hangzhou Children's Hospital: collaborator
• The First Hospital of Fuyang District, Hangzhou: collaborator
• The First Hospital of Xiaoshan District, Hangzhou: collaborator
• The First Hospital of Linping District, Hangzhou: collaborator
• The First Hospital of Lin'an District, Hangzhou: collaborator
• The First Hospital of Tonglu County, Hangzhou: collaborator
• The First Hospital of Jiande County, Hangzhou: collaborator
• The First Hospital of Chun'an County, Hangzhou: collaborator
• Affiliated Cixi Hospital of Wenzhou Medical University: collaborator
• Ningbo Medical Center Lihuili Hospital: collaborator
• Ningbo First People's Hospital: collaborator

Study Sites (1)

Second Affiliated Hospital, Zhejiang University School of Medicine & Institute of Emergency Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

Location

Study Officials

• Bin Zhang, masters

  Departmental staff

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Mao Zhang, MD

CONTACT

5718778465; zmhz@hotmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 7, 2021
• First Posted: July 28, 2021
• Study Start: August 1, 2021
• Primary Completion: August 30, 2021
• Study Completion: September 1, 2021
• Last Updated: July 28, 2021

Record last verified: 2021-06

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)